Xin Lang Cai Jing·2025-10-23 04:47Group 1 - The core viewpoint of the news is that Spring Medical's stock experienced a slight decline of 1.03% on October 22, with a trading volume of 155 million yuan, indicating a relatively stable market presence despite the drop [1] - On October 22, Spring Medical had a financing buy-in amount of 19.35 million yuan and a financing repayment of 18.11 million yuan, resulting in a net financing buy of 1.24 million yuan, with a total financing and securities balance of 43.62 million yuan as of the same date [1] - The financing balance of Spring Medical, which stands at 43.62 million yuan, accounts for 0.56% of its circulating market value and is above the 90th percentile level over the past year, indicating a high level of financing activity [1] Group 2 - Spring Medical, established on February 12, 1998, and listed on December 30, 2021, specializes in the research, production, and sales of implantable orthopedic medical devices, with its main products including joint prosthetics and spinal implants [2] - As of June 30, Spring Medical reported a revenue of 488 million yuan for the first half of 2025, representing a year-on-year growth of 28.27%, and a net profit attributable to shareholders of 114 million yuan, reflecting a 44.85% increase compared to the previous year [2] - The company has distributed a total of 359 million yuan in dividends since its A-share listing, with 309 million yuan distributed over the past three years [3] Group 3 - As of June 30, 2025, the number of shareholders in Spring Medical decreased by 17.57% to 5,920, while the average circulating shares per person increased by 341.41% to 48,836 shares [2] - Among the top ten circulating shareholders, Ping An Low Carbon Economy Mixed A (009878) is the fourth largest with 3.77 million shares, an increase of 2.77 million shares from the previous period, while Southern Medical Health Flexible Allocation Mixed A (000452) is a new entrant as the ninth largest shareholder with 1.60 million shares [3]